Sort
21,453 grants matching “tuberculosis”
Training in Geographic Medicine and Infectious Diseases
$266,601James Walter Kazura · Case Western Reserve University · T32 · FY2013 · AI
Protein Transport by the Bacterial Tat Machinery
$266,591Siegfried M Musser · Texas A&M University Health Science Ctr · R01 · FY2010 · GM
Development of a cell-based HTS for compounds with activity against tuberculosis
$266,495David G Russell · Cornell University · R01 · FY2011 · AI
Functional analysis of the MbtH-like protein superfamily
$266,376Michael G Thomas · University Of Wisconsin-Madison · R01 · FY2013 · GM
Mechanisms of Burkholderia Drug Tolerance and Pathogenesis
$266,236Martin Inua Voskuil · Colorado State University · U54 · FY2008 · AI
Emory-Georgia TB Research Training Program
$266,184Henry M Blumberg · Emory University · D43 · FY2015 · TW
The Phosphatidylethanol (PEth) Results Communication (PERC) Study
$266,133Judith Alissa Hahn · University Of California, San Francisco · R34 · FY2024 · AA
Fusidic acid derivatization to enhance entry into Gram-negative pathogens
$266,130James E Kirby · Beth Israel Deaconess Medical Center · R21 · FY2019 · AI
Diagnostics for AIDS-Related Pediatric TB, Peru
$266,110Tulane University Of Louisiana · R01 · FY2001 · AI
Systems Biology for Molecular Analysis of Tuberculosis in Ethiopia
$266,053Gobena Ameni · Addis Ababa University · U01 · FY2014 · HG
Isoprenoid Biosynthesis: A Target for Drugs Against Category A-C Pathogens
$266,008Dean C Crick · Colorado State University · U54 · FY2007 · AI
EARLY PULMONARY HOST DEFENSE IN M. TUBERCULOSIS INFECTIO
$266,000University Of Washington · R01 · FY2001 · HL
EARLY PULMONARY HOST DEFENSE IN M. TUBERCULOSIS INFECTIO
$266,000University Of Washington · R01 · FY2002 · HL
EARLY PULMONARY HOST DEFENSE IN M. TUBERCULOSIS INFECTIO
$266,000University Of Washington · R01 · FY2003 · HL
MYCOTHIOL BIOSYNTHESIS AND METABOLISM AS TB DRUG TARGETS
$266,000University Of California San Diego · R01 · FY2001 · AI
MYCOTHIOL BIOSYNTHESIS AND METABOLISM AS TB DRUG TARGETS
$266,000University Of California San Diego · R01 · FY2002 · AI
Mycobacteriophage as an emerging model organism
$265,979Graham F. Hatfull · University Of Pittsburgh At Pittsburgh · R24 · FY2014 · GM
Investigating the Role of the GTPase Arl8b in Plasma Membrane Repair of Mtb-Infected Macrophages
$265,938Heinz Gernot Remold · Brigham And Women'S Hospital · R21 · FY2015 · AI
Oral Pathogens and Dendritic Cell Subsets
$265,875Christopher W Cutler · State University New York Stony Brook · R01 · FY2010 · DE
OXIDANT INDUCED BETA CHEMOKINES IN GRANULOMA FORMATION
$265,858University Of Michigan At Ann Arbor · R01 · FY2000 · HL
Improving the effectiveness of anti-tuberculosis drugs by developing a point-of-care therapeutic drug monitoring system for areas with limited medical resources
$265,773Tian Lan · Glucosentient, Inc. · R43 · FY2024 · AI
Improved Methods for Membrane Protein Crystallization(RMI)
$265,679Michael C. Wiener · University Of Virginia · R01 · FY2008 · GM
Improved Methods for Membrane Protein Crystallization
$265,679Michael C. Wiener · University Of Virginia · R01 · FY2009 · GM
C25-modified rifabutin analogs as a novel medicinal chemistry strategy to overcome drug-resistant tuberculosis
$265,650Uday Ganapathy · Hackensack University Medical Center · R21 · FY2025 · AI
Using Collaborative Cross mice to develop a novel model of Mycobacterium abscesses lung infection
$265,650Martin Alfons Gengenbacher · Hackensack University Medical Center · R21 · FY2019 · AI